CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk

被引：0
|
作者：
Sohee Han
Kyoung-Mu Lee
Ji-Yeob Choi
Sue Kyung Park
Ji-Young Lee
Jong Eun Lee
Dong-Young Noh
Sei-Hyun Ahn
Wonshik Han
Dong-Hyun Kim
Yun-Chul Hong
Eunhee Ha
Keun-Young Yoo
Daehee Kang
机构：
[1] Seoul National University College of Medicine,Department of Preventive Medicine
[2] National Cancer Institute,Division of Cancer Epidemiology and Genetics
[3] Roswell Park Cancer Institute,Department of Epidemiology
[4] DNA Link Inc.,Department of Surgery
[5] Seoul National University College of Medicine,Department of Surgery
[6] Ulsan University College of Medicine,Department of Social and Preventive Medicine
[7] Hallym University College of Medicine,Department of Preventive Medicine
[8] Ewha Womans University,Cancer Research Institute
[9] Korea National Cancer Center,undefined
[10] Seoul National University,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 110卷
关键词：
Breast cancer; Estrogen receptor; Polymorphism; Progesterone receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 393
页数：6
相关论文
共 50 条
  • [21] Association of CASP8 polymorphisms and cancer susceptibility: A meta-analysis
    Hashemi, Mohammad
    Aftabi, Sajjad
    Moazeni-Roodi, Abdolkarim
    Sarani, Hosna
    Wiechec, Emilia
    Ghavami, Saeid
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 881
  • [22] Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status
    Rusiecki J.A.
    Holford T.R.
    Zahm S.H.
    Zheng T.
    European Journal of Epidemiology, 2004, 19 (8) : 793 - 801
  • [23] Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status
    Zhang, Min
    Yang, Hongjian
    Holman, C. D'Arcy J.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (03) : 553 - 563
  • [24] Discordant Estrogen and Progesterone Receptor Status in Breast Cancer
    Hefti, M. M.
    Hu, R.
    Knoblauch, N.
    Collins, L.
    Tamimi, R. M.
    Beck, A. H.
    CANCER RESEARCH, 2012, 72
  • [25] Dietary intake of isoflavones and breast cancer risk by estrogen and progesterone receptor status
    Min Zhang
    Hongjian Yang
    C. D’Arcy J. Holman
    Breast Cancer Research and Treatment, 2009, 118 : 553 - 563
  • [26] Differences in breast cancer risk factors by estrogen and progesterone receptor status.
    Byrne, C
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 143 (11) : 131 - 131
  • [27] Polychlorinated biphenyls and breast cancer risk by combined estrogen and progesterone receptor status
    Rusiecki, JA
    Holford, TR
    Zahm, SH
    Zheng, TZ
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2004, 19 (08) : 793 - 801
  • [28] A promoter polymorphism in the CASP8 gene is not associated with cancer risk
    Christopher A Haiman
    Rachel R Garcia
    Laurence N Kolonel
    Brian E Henderson
    Anna H Wu
    Loïc Le Marchand
    Nature Genetics, 2008, 40 : 259 - 260
  • [29] A promoter polymorphism in the CASP8 gene is not associated with cancer risk
    Haiman, Christopher A.
    Garcia, Rachel R.
    Kolonel, Laurence N.
    Henderson, Brian E.
    Wu, Anna H.
    Le Marchand, Loic
    NATURE GENETICS, 2008, 40 (03) : 259 - 260
  • [30] Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk
    Vang, Alecia
    Salem, Kelley
    Fowler, Amy M.
    ENDOCRINOLOGY, 2023, 164 (04)
12345